A detailed history of Rodgers Brothers Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rodgers Brothers Inc. holds 79,332 shares of BMY stock, worth $4.55 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
79,332
Previous 54,371 45.91%
Holding current value
$4.55 Million
Previous $2.26 Million 81.8%
% of portfolio
0.57%
Previous 0.33%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $989,953 - $1.29 Million
24,961 Added 45.91%
79,332 $4.11 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $479,095 - $630,739
11,903 Added 28.03%
54,371 $2.26 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $54,457 - $61,744
1,135 Added 2.75%
42,468 $2.3 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $789,739 - $942,376
-16,290 Reduced 28.27%
41,333 $2.12 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $233,470 - $261,056
4,033 Added 7.53%
57,623 $3.34 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $227,126 - $252,188
3,565 Added 7.13%
53,590 $3.43 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $1.51 Million - $1.72 Million
23,050 Added 85.45%
50,025 $3.47 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $29,446 - $34,868
-430 Reduced 1.57%
26,975 $1.94 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $4,684 - $2.77 Million
-36,036 Reduced 56.8%
27,405 $1.95 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $20,115 - $22,154
-277 Reduced 0.43%
63,441 $4.89 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $938,525 - $1.09 Million
17,500 Added 37.86%
63,718 $3.97 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $11,834 - $13,862
200 Added 0.43%
46,218 $2.74 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $640,768 - $697,797
10,350 Added 29.02%
46,018 $3.08 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $100,878 - $113,457
1,700 Added 5.0%
35,668 $2.25 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $5,774 - $6,543
-100 Reduced 0.29%
33,968 $2.11 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $780,243 - $864,613
13,586 Added 66.33%
34,068 $2.05 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $26,149 - $30,570
477 Added 2.38%
20,482 $1.2 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $11,785 - $17,127
254 Added 1.29%
20,005 $1.12 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $971,946 - $1.27 Million
19,751 New
19,751 $1.27 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $229,803 - $272,464
-5,373 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $41,496 - $45,886
930 Added 20.93%
5,373 $244,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $541 - $645
12 Added 0.27%
4,443 $212,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $23,794 - $30,856
-488 Reduced 9.92%
4,431 $230,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $551 - $622
10 Added 0.2%
4,919 $305,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $248,051 - $309,168
4,909 New
4,909 $272,000
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $406,692 - $443,399
-6,785 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $374,735 - $432,475
6,785
6,785 $432,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Rodgers Brothers Inc. Portfolio

Follow Rodgers Brothers Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.